The global bio-implants market size was USD 135.9 Bn in 2022 and is likely to reach USD 321.8 Bn by 2031, expanding at a CAGR of 10.3% during, 2023–2031. The market growth is attributed to the rapid increase in the geriatric population, elevated focus on health & expenses, and advancements in medical sciences.
Bioimplants are prostheses that introduce foreign materials into the human body with an aim of administering physical implants or specific drugs. Bio-implants are developed based on extensive research outputs regarding the properties of the material to be used in implants.
Extensive research of properties related to organ and tissue replacement is carried out. This is done as implants are deemed to perform human body functions on being implanted.
Bioimplant material selection and implantation primarily focus on the biocompatibility of the human body with the material to be introduced as an implant. This includes testing and information gathering of the levels of tolerance of the human body towards the released material ions. An in-depth record of a material’s biodegradation behavior is maintained and analyzed.
Administering therapeutics using biomaterial metals as implants is on the rise for critical ailments such as cancer. This includes immunomodulatory agent carriers that aid in stimulating and in the multiplication of immune cells that stimulates the immune system in a controlled way.
COVID-19 Impact on Bio-implants Market
The market report finds that the COVID-19 pandemic affected the bio-implants market size due to the decreased number of patients opting for implant procedures during the pandemic all around the world. The COVID-19 spread affected the market adversely, with governments announcing complete lockdowns and national emergencies in respective countries leading to surgery procedures coming to a standstill. People feared virus infections with risks of exposure to the virus during clinical implantation procedures, owing to which many opted for alternative measures or postponing the implant treatments.
Bio-implants Market Dynamics
The research report presents a complete market overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global bio-implants market report has up-to-date insights about market scenarios that can shape the overall market performance and output during the forecast period, 2023 to 2031.
What are Trends in the Bio-implants Market?
- Demand for Minimal Invasive Surgeries
A major trend in the bioimplants market is the upward demand for minimally invasive surgeries. Creating incisions that are minute for reaching surgical points is a major advantage of minimally invasive surgical procedures. Endoscopic and laparoscopic bio-implanting procedures are possible through minimally invasive surgeries. The creation of small incisions relieves pain and rapid postoperative recovery.
What are Drivers of the Bio-implants Market?
- Rising Geriatric Population
The number of elderly geriatric people, above 80 years of age is increasing with betterment in the standards of living coupled with advancements in the medical field. Older adults are disinterested in opting for lengthy medical treatments, which is likely to drive the demand for bio-implants in this age group in the coming years.
Major surgical operations are avoided by doctors due to the fear of medical complications arising in people of higher age groups which is a boosting factor for market growth. Most geriatric people suffer from ailments of the eyesight and joints primarily. Catering to these ailments is possible through the use of retinal bioimplants and joint replacements of the knees or the hip.
- Growing Inclination Towards Opting for Cosmetic Procedures
Implants through surgical procedures for cosmetic surgeries have increased as youth are interested in enhancing their looks, which has significantly boosted the demand for biological implants. Increased standards of living have contributed to this rise too. The cosmetic surgeries opted for by youth include dental procedures such as implanting artificial teeth, jawline and cheekbone modifications, breast upliftment, and several beauty-enhancing modifications that are carried out using cosmetic dentistry procedures.
- Increasing Organ Failure Instances and Lesser Organ Donors
Patients in the last stages of chronic ailments of kidney failures or heart-related problems have no option but to opt for implants which is a major market driver. Donors for such critical organs are extremely difficult to be found. Even if a donor is found the necessary medical matching of his/her organs to those of the receptor is a major concern.
In such cases, biological implants pave the way for less complex treatment of chronic health problems to save scores of lives. Apart from the complete substitution of the affected organ, bio-implants have assisted patients in improving the functioning of organs that are partially healthy and functioning at decreased operating levels.
What are Restraints of the Bio-implants Market?
- High Cost of Implanting Procedures
Implanting procedures are extremely costly due to the high import costs of implant materials along with getting the procedures performed by skilled doctors. Dental implants for a single tooth generally cost in the high ranges.
Costs for chronic ailments with critical organ implants are extravagantly high. These include retinal implants, stents for cardiac implants, spinal implants, and cosmetic implants which are significantly likely to restrain the market growth.
- Biomaterial Adaptation to Receptive Bodies
The effectiveness of embedded implants in the human body is directly linked to the human body adapting to the material. The probability of immunity reactions in the body is a major factor to gauge this effectiveness. Infections caused due to implant materials have been reported due to bacteria sticking onto biomaterials used for implants impacting the market growth.
Allergic reactions of the body to foreign implanted materials cause discomfort to patients. Treatment in such cases mostly involves removing the implanted material and substituting it with other materials suited to the body. Problems arise at the site of implantation through material rejection by the human body. It is visible through inflammations and infections seen in and around the implant site.
Which are Opportunities in the Bio-implants Market?
- Increasing Chronic Diseases due to Stressful Lifestyles
Chronic diseases of the heart, kidneys, and liver are rising every day due to stressful lifestyles and unhealthy living. Treatments for such ailments are carried out through organ and tissue transplantation and by implanting bio-implants. Other critical ailments are degeneration of bones and joint problems. These health problems are on the rise due to an increase in the geriatric population around the world is a major opportunity for the growth of the bio-implants market.
Orthopedic biological implants for joint replacements and strengthening are preferred for curing a deformity – natural, accidental, or due to a congenital defect. The use of implants in the form of pacemakers and stents for heart ailments is growing. The growth is for cardiovascular disease control and treatment in the geriatric population around the world.
- Genetically Engineered Biomaterials
Naturally available biomaterials such as proteins are selectively modified for tissue engineering. This primarily involves cell adhesion and protein fusions that are applied in gene delivery, cell encapsulating and coating, and drug delivery and are likely to boost the growth prospects of the market.
Genetically engineered biomaterials involve sequencing processes based on genetics, structure, molecular weights, and fusion chemistries. A boom is predicted in the production of biomaterials using physical and chemical combinations in genetic engineering. Such focused production of biomaterials through intrinsic research aids in improving the effectiveness of implants.
Research for developing artificial skin through specialized biomaterial is a major opportunity driver for the cosmetic biomaterial market expansion. Varied forms of sponge combining fibrillar collagen and gelatin are being evaluated. This evaluation is based on in vitro cellular responses and in vivo tissue reactions. The evaluation includes in vivo experimentation done in a whole organism such as in vivo cell lining.
Scope of Bio-implants Market Report
The global bio-implants market research report includes an assessment of the market trends, market segments, and regional analysis of markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Bio-implants Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2020–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Material (Biomaterial Metals, Alloys, Ceramics, and Polymers), Origin (Xenografts, Allografts, Synthetics, and Autografts), Product (Orthopedic, Dental, Cardiovascular, Ophthalmic, Cosmetic, Spinal, Sports Medicine, and Others), Mode of Administration (Surgical and Non-Surgical), and End-user (Specialty Clinics, Ambulatory Surgical Centers, and Hospitals)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Zimmer Biomet; aap Implantate AG; Abbott; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; Smith+Nephew; Medical Device Business Services, Inc.; ALPHA BIO TEC; LifeNet Health; Arthrex, Inc.; MIMEDX; Medtronic; Cochlear Ltd.; Clinic Lémanic; Institut Straumann AG; Stryker; and Exactech, Inc.
|
Bio-implants Market Segment Insights
Which Major Factors Influence the Significant Growth of the Biomaterial Metals Segment?
Based on the material segment, the global bio-implants market is divided into biomaterial metals, alloys, ceramics, and polymers. The biomaterial metal segment is expected to expand at a significant growth rate during the projected period owing to less time required for implant fixation procedures. Cardiovascular implants are used as pacemakers and in heart valve replacement surgeries. Prosthetic & orthodontic devices, facial plates & screws, and bone fixation materials are widely used biomaterials in biomedical applications.
Bio-material metal implants formed out of titanium alloys, aluminum alloys, zirconium-niobium, stainless steel, cobalt-chromium alloys, and tungsten alloys have gained popularity due to several advantages they offer. The favorable biocompatibility of metal alloys with the human body is of significant advantage. Superior corrosion resistance and better tensile strength of biomaterial metallic implants make them a preferred choice over other materials.
The ceramic implants segment is anticipated to hold a key share of the market in the coming years due to its aesthetic appeal, especially for dental implants. Inflammations are negated due to improved gap-filling between the implant and the abutment. Advanced ceramic implants have a gingival attachment which is better than other materials reducing the probability of gingivitis.
What Key Factors Contribute to the Rapid Expansion of the Xenograft Segment?
On the basis of origin, the bio-implants market is divided into xenografts, allografts, synthetics, and autografts. The xenograft segment is expected to expand at a significant growth rate during the projected period with extensive research-led progress in tissue engineering and vascular engineering. The treatments make use of scaffolds made out of polymeric biomaterials that provide structural support for cell and tissue development.
The allografts segment is anticipated to hold a key share of the market in the coming years owing to the reduction in surgical procedural time. Bone regeneration tissue that is decellularized and demineralized after sterilization is extensively in demand. Allografts allow for avoiding surgeries with larger incisions.
What are the Main Aspects for Boosting the Orthopedic Segment?
Based on product, the global market is segregated into orthopedics, dental, cardiovascular, ophthalmic, cosmetic, spinal, sports medicine, and others. The orthopedics segment is projected to register a considerable CAGR during the forecast period for bio-implants with increasing accidental injuries around the globe.
Effective treatment for orthopedic trauma injuries is possible through bio-implant procedures. Musculoskeletal injuries of the joints, ligaments, bones, muscles, and tendons are effectively treatable through bio-implants.
The dental implants segment is anticipated to account for a major market share in the coming years as implants are preferred over bridges and dentures for cases of decaying teeth and tooth loss. Dental implants aid in preventing bone loss thus preserving the bone structure.
The use of dental implants involves surgical procedures that fix metallic frames through insertions into the gums. Bio-implants for dental implants act as crowns for supporting artificial teeth. They act as substitutes for natural teeth and help properly chew food.
Which Major Factors Influence the Significant Growth of the Non-Surgical Segment?
On the basis of the mode of administration, the market is segmented into surgical and non-surgical implant procedures. Non-surgical implants are expected to expand at a significant growth rate during the projected period due to the need for less recovery time post the implanting procedure.
Incision procedure without sutures expedites the implanting process. Minimal discomfort and pain are experienced by the patient. Predictive results with nominal healing time are other advantages for segment growth. The demand for minimally invasive or non-surgical implants is growing in dental care. Non-surgical bio-implants are preferred by patients over dental procedures such as root canal treatments.
The surgical bio-implants segment is anticipated to grow at a considerable rate during the forecast period. They are used for treating critical ailments. The implantation of grafts, heart valves, and stents are rising for cardiovascular disease treatments. Bio-implant supports for tendons and ligaments, and artificial joints are surgically implanted through orthopedic surgeries.
What are the Main Aspects for Boosting the Hospitals Segment?
Based on the end-user segment, the market is categorized into specialty clinics, ambulatory surgical centers, and hospitals. Hospitals hold the dominant market share due to the increased patient influx of the elderly, and geriatric population, and the growing demand for chronic disease treatment. The elderly, who form the geriatric population, need implantation for joint problems and chronic ailments such as cardiovascular diseases.
Majorly chronic disease complications are treatable only in specialized hospitals that involve complex surgical procedures. For instance, joint and hip replacement procedures require focused medical attention for implanting. As a result, doctors refer patients to multi-specialty hospitals preferring over clinics.
The specialty clinics segment is expanding rapidly in the global market owing to the need for catering to cosmetic surgery demands and less severe ailments such as dental complications. Patients opting for cosmetic procedures with an increased awareness of maintaining presentable personalities have boosted the segment.
An increase in disposable income has fueled the tendency to opt for implants at specialty clinics. Bio-implants are widely used by ambulatory surgery centers and outpatient service providers for less complex surgeries. The hospitalization duration of patients availing of ambulatory services is minimal, generally not exceeding 24 hours.
Why is North America Dominating the Bio-implants Market?
In terms of region, the global bio-implants market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the bio-implants market during the projected period due to the rising occurrences of orthopedic disorders in the American population. The adoption of the latest biomedical engineering techniques in healthcare is expected to fuel market expansion.
North America is anticipated to be the market leader due to an increase in surgeries needing implants. An upsurge in adopting advanced medical technologies is predicted to further drive market growth in North America.
The market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period with the increased accident cases in the region. The increasing cases of spinal cord injury in accidental cases are driving the demand for bio-implants in Asia Pacific. Substitutes are used for spinal cord injury through graft techniques.
Artificial bone grafts, allografts, and autologous bone grafts make up the spinal fusion bone graft substitutes. Developed and developing countries of the Asia Pacific region such as China, India, and Australia are scaling up healthcare infrastructures. These initiatives are generating awareness among the citizens and aiding in reducing accidents and improving treatments for serious injuries.
Segments
The global bio-implants market has been segmented on the basis of
Material
- Biomaterial Metals
- Alloys
- Ceramics
- Polymers
Origin
- Xenografts
- Allografts
- Synthetics
- Autografts
Product
- Orthopedic
- Dental
- Cardiovascular
- Ophthalmic
- Cosmetic
- Spinal
- Sports Medicine
- Others
Mode of Administration
End User
- Specialty Clinics
- Ambulatory Surgical Centers
- Hospitals
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Zimmer Biomet
- aap Implantate AG
- Abbott
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Smith+Nephew
- Medical Device Business Services, Inc.
- ALPHA BIO TEC
- LifeNet Health
- Arthrex, Inc.
- MIMEDX
- Medtronic
- Cochlear Ltd.
- Clinic Lémanic
- Institut Straumann AG
- Stryker
- Exactech, Inc.
Competitive Landscape
The competitive landscape of the global bio-implants market report provides key insights into the growth strategies and development initiatives implemented by the key players in the market.
Key players competing in the bio-implants market are Zimmer Biomet; aap Implantate AG; Abbott; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; Smith+Nephew; Medical Device Business Services, Inc.; ALPHA BIO TEC; LifeNet Health; Arthrex, Inc.; MIMEDX; Medtronic; Cochlear Ltd.; Clinic Lémanic; Institut Straumann AG; Stryker; and Exactech, Inc.
- On February 15, 2022, an American manufacturer of medical devices and biomedical engineering, Boston Scientific Corporation, acquired another US-based firm manufacturing medical devices, Baylis Medical Company Inc. for integrating electrophysiology and structural heart offerings to strengthen its position as a leading contributor in the cardiovascular implants market.
- On January 19, 2022, Smith & Nephew PLC., a British multinational medical equipment manufacturing company, acquired a US-based company, Engage Surgical to create the only cementless unicompartmental knee system in the US.
- On December 01, 2020, a US-based leader in musculoskeletal healthcare, Zimmer Biomet, acquired A&E Medical, an American manufacturer of high-strength sternum closure systems and a wide variety of cardiac materials.
Request For Customization
Enquiry Before Buying
Speak With Analyst
